Companies · Other Health Care

ConforMIS Inc

BEDFORD · Other Health Care

Diligence memoA one-page analyst read on ConforMIS Inc — recommendation, valuation, rhythm, risks.
$688.7M
Total raised · real
14
Rounds
0.0×
Latest step-up
Top 1%
Sector rank · raised
Series C
Latest stage · inferred · Fri Nov 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)

ConforMIS Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.01× the median modeled value of Series C Other Health Care companies in 2013–2015 (33 peers) — value vs value, same stage and era.
Dormant
  • Last raise 11.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

ConforMIS Inc is one of 5377 Other Health Care companies tracked from BEDFORD. By capital raised it ranks among the largest (ahead of 100% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3B$2.5B$3.8B$5.0BSeries C · Raised $68M (real) Modeled valuation $332M (est)Series CSeries C · Raised $68M (real) Modeled valuation $332M (est)Series CSeries C · Raised $60M (real) Modeled valuation $293M (est)Series CSeries C · 2008-06-18 Raised $50M (real) Modeled valuation $1.1B (est)Series C2008Series C · 2008-06-18 Raised $75M (real) Modeled valuation $1.7B (est)Series C2008Series C · 2008-06-18 Raised $51M (real) Modeled valuation $1.2B (est)Series C2008Series C · 2009-08-11 Raised $1.2M (real) Modeled valuation $27M (est)Series C2009Series C · 2009-12-30 Raised $2.2M (real) Modeled valuation $49M (est)Series C2009Series C · 2011-02-16 Raised $1.8M (real) Modeled valuation $41M (est)Series C2011Series C · 2011-06-24 Raised $41M (real) Modeled valuation $941M (est)Series C2011Series C · 2011-06-24 Raised $97M (real) Modeled valuation $2.2B (est)Series C2011Series C · 2011-06-24 Raised $85M (real) Modeled valuation $1.9B (est)Series C2011Series C · 2011-10-18 Raised $83M (real) Modeled valuation $1.9B (est)Series C2011Series C · 2011-10-18 Raised $73M (real) Modeled valuation $1.7B (est)Series C2011Series C · 2014-11-07 Raised $600K (real) Modeled valuation $14M (est)Series C2014Cumulative $757M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$68.0M
Series C extension$68.0M
Series C extension$60.0M
Series C extension$50.3M · 2008
Series C extension$74.9M · 2008
Series C extension$51.2M · 2008
Series C extension$1.2M · 2009
Series C extension$2.2M · 2009
Series C extension$1.8M · 2011
Series C extension$41.2M · 2011
Series C extension$97.1M · 2011
Series C extension$85.1M · 2011
Series C extension$82.7M · 2011
Series C extension$72.7M · 2011
Series C extension$600K · 2014

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$13.7M
Base estimate est.
$2.2M
Conservative case
$36.1M
Upside case
$4.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series C · modeled $332.4M · Series C · modeled $332.4M · Series C · modeled $293.3M · Series C · modeled $1.1B · 2008-06-18Series C · modeled $1.7B · 2008-06-18Series C · modeled $1.2B · 2008-06-18Series C · modeled $27.4M · 2009-08-11Series C · modeled $49.3M · 2009-12-30Series C · modeled $41.2M · 2011-02-16Series C · modeled $941.3M · 2011-06-24Series C · modeled $2.2B · 2011-06-24Series C · modeled $1.9B · 2011-06-24Series C · modeled $1.9B · 2011-10-18Series C · modeled $1.7B · 2011-10-18Series C · modeled $13.7M · 2014-11-072014
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
6.0 yr
Elapsed time used
11.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
38 mo
Avg between rounds
$15.4M/yr
Capital velocity
56.5 yr
On record since
1970
First round
15
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 283× above median
This company$688.7M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.0× of median
This company$600K
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 0.6× of median
This company$13.7M
Sector median$22.1M

Raised more than 100% of sector peers (real $). Modeled value above 40% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #33 of 33.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)ACON IWP Holdings, L.L.C. · Series C Raised $91.8M · modeled $2.1B (est)Erc Group Holdings, Llc · Series C Raised $91.7M · modeled $2.1B (est)Cpf Senior Living Holdings, Llc · Series C Raised $158.4M · modeled $2.0B (est)Corvus Pharmaceuticals, Inc. · Series C Raised $87.7M · modeled $1.7B (est)TVG-SHC Holdings, LLC · Series C Raised $70.4M · modeled $1.6B (est)Sequel Youth & Family Services, LLC · Series C Raised $97.8M · modeled $1.5B (est)Wave Life Sciences Pte Ltd · Series C Raised $77.8M · modeled $1.5B (est)MedSynergies, Inc. · Series C Raised $118.0M · modeled $1.5B (est)HALT Medical, Inc · Series C Raised $177.7M · modeled $1.4B (est)Med Fusion, LLC · Series C Raised $92.9M · modeled $1.4B (est)Data Driven Delivery Systems, LLC · Series C Raised $67.0M · modeled $1.4B (est)Remedy Partners, Inc. · Series C Raised $110.0M · modeled $1.4B (est)ConforMIS Inc (this company) Raised $688.7M · modeled $13.7M (est)ConforMIS Inc
CompanyStageRaised · realValue · estvs peer med.
ACON IWP Holdings, L.L.C.Series C$91.8M$2.1B1.84×
Erc Group Holdings, LlcSeries C$91.7M$2.1B1.83×
Cpf Senior Living Holdings, LlcSeries C$158.4M$2.0B1.72×
Corvus Pharmaceuticals, Inc.Series C$87.7M$1.7B1.50×
TVG-SHC Holdings, LLCSeries C$70.4M$1.6B1.41×
Sequel Youth & Family Services, LLCSeries C$97.8M$1.5B1.32×
Wave Life Sciences Pte LtdSeries C$77.8M$1.5B1.32×
MedSynergies, Inc.Series C$118.0M$1.5B1.30×
HALT Medical, IncSeries C$177.7M$1.4B1.27×
Med Fusion, LLCSeries C$92.9M$1.4B1.22×
Data Driven Delivery Systems, LLCSeries C$67.0M$1.4B1.22×
Remedy Partners, Inc.Series C$110.0M$1.4B1.20×
ConforMIS Inc this companySeries C$688.7M$13.7M0.01×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$50.3M2008-06-18$335.2M$1.1B90%
Series C$74.9M2008-06-18$499.2M$1.7B90%
Series C$51.2M2008-06-18$341.1M$1.2B90%
Series C$1.2M2009-08-11$8.0M$27.4M90%
Series C$2.2M2009-12-30$14.4M$49.3M90%
Series C$1.8M2011-02-16$12.0M$41.2M90%
Series C$41.2M2011-06-24$274.5M$941.3M90%
Series C$97.1M2011-06-24$647.1M$2.2B90%
Series C$85.1M2011-06-24$567.0M$1.9B90%
Series C$82.7M2011-10-18$551.1M$1.9B90%
Series C$72.7M2011-10-18$484.4M$1.7B90%
Series C$600K2014-11-07$4.0M$13.7M90%
Series C$68.0M$453.3M$332.4M90%
Series C$68.0M$453.3M$332.4M90%
Series C$60.0M$400.0M$293.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$50.3M2008-06-18
    • First recorded raise — entered as Series C.
  2. Series C$74.9M2008-06-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
  3. Series C$51.2M2008-06-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
  4. Series C$1.2M2009-08-11
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 42.6× smaller than the prior — bridge or down round.
  5. Series C$2.2M2009-12-30
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 1.8× larger than the prior — scaling up.
  6. Series C$1.8M2011-02-16
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  7. Series C$41.2M2011-06-24
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 22.9× larger than the prior — scaling up.
  8. Series C$97.1M2011-06-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.4× larger than the prior — scaling up.
  9. Series C$85.1M2011-06-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  10. Series C$82.7M2011-10-18
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  11. Series C$72.7M2011-10-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  12. Series C$600K2014-11-07
    • Raised again after 37 mo — slower than the ~14 mo sector norm.
    • Round 121.1× smaller than the prior — bridge or down round.
Intelligence
2018 ~Q1
Modeled next raise · ~38mo cadence
$600K
Modeled next size est.range $600K$960K
0.0×
Last step-up
$15.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Aditya Puri3 other2011-06
Frank Muhlenbeck3 other2008-06
Michael Milligan2 other2011-06
Philipp Lang2 other2008-06
Judith M. Huber1 other2011-02
Paul Weiner1 other2011-06
Aditya M. Puri2011-06
Anselm Leung2008-06
Anselm M. Leung2011-02
Brad Langdale2008-06
Brad M. Langdale2011-02
Colm Christopher Lanigan2011-06
David Christopher Cerveny2011-06
Frank M. Muhlenbeck2011-02
Judy Huber2008-06
Ken Fallon2008-06
Ken M. Fallon2011-02
Laurent M. Souviron2011-06
Laurent Souviron2011-06
Michael M. Milligan2011-06
Peter Traynor2011-06
Phil Licari2008-06
Registry & provenance

ConforMIS Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1305773
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Optiscan Biomedical CorpOther Health CareSeries B$131.6M$443.1Mnetwork1 shared operator · same sector
Genomedx Inc.Other Health CareSeries B$72.9M$176.3Mnetwork1 shared operator · same sector
NinePoint Medical, Inc.Other Health CareSeries B$70.4M$679.4Mnetwork1 shared operator · same sector
Oliver Street Dermatology Holdings LLCOther Health CareSeries C$109.7M$13.1Msame sector · same stage
VITTAMED CorpOther Health CareSeries A$5.0M$101.5Mnetwork1 shared operator · same sector
HighRes Biosolutions, Inc.Other Health CareSeed$2.5M$61.5Mnetwork1 shared operator · same sector
AxelaCare Holdings, Inc.Other Health CareSeries C$66.5M$12.0Msame sector · same stage
OnPoint Knee, Inc.Other Health CarePre-Seed$200K$6.2Mnetwork1 shared operator · same sector
Frequently asked
How much funding has ConforMIS Inc raised?
ConforMIS Inc has raised approximately $688.7M in disclosed capital across 14 recorded financing rounds, aggregated from public filings.
What is ConforMIS Inc's estimated valuation?
Provath's modeled valuation for ConforMIS Inc is approximately $13.7M (modeled range $2.2M–$36.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is ConforMIS Inc at?
ConforMIS Inc's latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Nov 07.
What does ConforMIS Inc do and where is it based?
ConforMIS Inc operates in the Other Health Care sector, based in BEDFORD.
Explore related

See where ConforMIS Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at ConforMIS Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.